Salivary gland cancer organoids are valid for preclinical genotype-oriented medical precision trials
Summary: Salivary gland cancers (SGCs) are heterogeneous tumors, and precision oncology represents a promising therapeutic approach; however, its impact on SGCs remains obscure. This study aimed to establish a translational model for testing molecular-targeted therapies by combining patient-derived...
Main Authors: | Tomohiko Ishikawa, Takenori Ogawa, Masahiro Shiihara, Hajime Usubuchi, Yuko Omori, Katsuya Hirose, Taito Itoh, Takuya Yoshida, Ayako Nakanome, Akira Okoshi, Kenjiro Higashi, Ryo Ishii, Masahiro Rokugo, Shun Wakamori, Yasunobu Okamura, Kengo Kinoshita, Yukio Katori, Toru Furukawa |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-05-01
|
Series: | iScience |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589004223007721 |
Similar Items
-
Long Non-Coding RNAs Associated with Mitogen-Activated Protein Kinase in Human Pancreatic Cancer
by: Tomohiko Ishikawa, et al.
Published: (2023-01-01) -
Application of Patient-Derived Cancer Organoids to Personalized Medicine
by: Masahiro Shiihara, et al.
Published: (2022-05-01) -
Single-cell RNA-seq public data reveal the gene regulatory network landscape of respiratory epithelial and peripheral immune cells in COVID-19 patients
by: Lin Zhang, et al.
Published: (2023-10-01) -
Identification of BST2 as a conjunctival epithelial stem/progenitor cell marker
by: Masahiro Kitao, et al.
Published: (2023-07-01) -
Cell death induction and protection by activation of ubiquitously expressed anion/cation channels. Part 3: the roles and properties of TRPM2 and TRPM7
by: Yasunobu Okada, et al.
Published: (2023-09-01)